New study results presented at the European Lung Cancer Congress (ELCC) 2025, 26 to 29 March, demonstrate the role of AstraZeneca’s Tagrisso (osimertinib), as monotherapy and as the backbone for novel ...
Based on NIAGARA Phase III trial results which showed a 32% reduction in the risk of recurrence and a 25% reduction in the risk of death vs. neoadjuvant ...
REDWOOD CITY, CA, USA I March 31, 2025 I Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development ...
AstraZeneca’s Imfinzi receives US FDA approval for patients with muscle-invasive bladder cancer: Cambridge, UK Tuesday, April 1, 2025, 10:00 Hrs [IST] AstraZeneca’s Imfinzi (d ...
Verywell Health on MSN1d
What Happens to Your Body When You Eat Dragon FruitDragon fruit is a tropical superfood packed with vitamins, antioxidants, and fiber. Among many benefits, it can boost ...
AstraZeneca’s IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...
Liberation Day’ tariffs to be effective immediately, White House says - Trump prepares sweeping round of reciprocal tariffs ...
Over a spread of delicious pan-Asian delicacies from Yazu ... friend of hers who has become a major source of strength for Hina. She lives in South Africa and is a cancer survivor herself. Turns out, ...
Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced a ...
6hon MSN
In countries around the world, evidence suggests people from CALD backgrounds are at increased risk of harm as a result of ...
Sequencing the human genome enables scientists to study human biology in a granular fashion and use that information to create treatments for things like cancer. Yet, of the human genomes studied so ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback